- Home
- JSPR vs OSUR Comparison
JSPR vs OSUR Comparison
Compare JSPR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JSPR | OSUR |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1M | 215.9M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | JSPR | OSUR |
|---|---|---|
| Price | $0.83 | $2.99 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $15.50 | $3.00 |
| AVG Volume (30 Days) | 272.2K | ★ 509.3K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $2.08 |
| 52 Week High | $7.19 | $3.76 |
Technical Indicators
Market Signals| Indicator | JSPR | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 47.23 |
| Support Level | $0.81 | $2.87 |
| Resistance Level | $1.03 | $3.24 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 12.81 | 29.26 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.